1.Dispenzieri A. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92(8):814–29.
2.Cui R, Yu S, Huang X, Zhang J, Tian C, Pu C. Papilloedema is an independent prognostic factor for POEMS syndrome. J Neurol. 2014;261(1):60–5.
3.Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, et al. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. British Journal of Ophthalmology. 2016;100(7):897–901.
4.Yokouchi H, Baba T, Misawa S, Sawai S, Beppu M, Kitahashi M, et al. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome. Graefes Arch Clin Exp Ophthalmol. 2015;253(10):1641–6.
5.Yokouchi H, Baba T, Misawa S, Kitahashi M, Oshitari T, Kuwabara S, et al. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol. 2017;101(6):786–90.
6.Zhang X, Cai QQ, Huang XF, Cao XX, Cai H, Zhou DB, et al. Ocular Manifestations and Treatment Outcomes in Chinese Patients with Poems Syndrome. Retina. 2017;37(9):1784–91.
7.Dispenzieri A. POEMS syndrome. Blood Reviews. 2007;21(6):285–99.
8.Scott CJ, Kardon RH, Lee AG, Frisen L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010;128(6):705–11.
9.Cai QQ, Wang C, Cao XX, Cai H, Zhou DB, Li J. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome. Eur J Haematol. 2015;95(4):325–30.
10.Chong DY, Comer GM, Trobe JD. Optic disc edema, cystoid macular edema, and elevated vascular endothelial growth factor in a patient with POEMS syndrome. J Neuroophthalmol. 2007;27(3):180–3.
11.Kaushik M, Pulido JS, Abreu R, Amselem L, Dispenzieri A. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology. 2011;118(4):778–82.
12.Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet. 1996;347(9002):702.
13.D’Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011;118(17):4663–5.
14.Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, et al. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 2015;5(11):e009157-e.
15.Zhao H, Cai H, Wang C, Huang XF, Cao XX, Zhang L, et al. Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome. Blood Cancer J. 2018;8(4):37.
16.Hwang YH, Yoo C, Kim YY. Myopic optic disc tilt and the characteristics of peripapillary retinal nerve fiber layer thickness measured by spectral-domain optical coherence tomography. J Glaucoma. 2012;21(4):260–5.
17.Laemmer R, Horn FK, Viestenz A, Juenemann AG, Mardin CY. Influence of optic disc size on parameters of retinal nerve fiber analysis with laser scanning polarimetry. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):603–8.
18.Seo S, Lee CE, Jeong JH, Park KH, Kim DM, Jeoung JW. Ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness according to myopia and optic disc area: a quantitative and three-dimensional analysis. BMC Ophthalmol. 2017;17(1):22.
19.Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, et al. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurg Psychiatry. 2013;84(12):1346–8.
20.Hudson N, Powner MB, Sarker MH, Burgoyne T, Campbell M, Ockrim ZK, et al. Differential Apicobasal VEGF Signaling at Vascular Blood-Neural Barriers. Dev Cell. 2014;30(5):541–52.
21.Iwase T, Yokouchi H, Misawa S, Oshitari T, Baba T, Kuwabara S, et al. Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome. Neuro-Ophthalmology. 2017;42(1):25–30.
22.Cohen AI. Is there a potential defect in the blood-retinal barrier at the choroidal level of the optic nerve canal? Investigative ophthalmology. 1973;12(7):513–9.
23.Dai RP, Dong FT, Chu J. [Ocular features of polyneuropathy-organomegaly-endocrinopathy-monoclonal gammopathy-skin changes syndrome]. Zhonghua Yan Ke Za Zhi. 2005;41(10):917–9.
24.Wong VA, Wade NK. POEMS syndrome: an unusual cause of bilateral optic disk swelling. Am J Ophthalmol. 1998;126(3):452–4.
25.Xu L, Li Y, Wang S, Wang Y, Wang Y, Jonas JB. Characteristics of highly myopic eyes: the Beijing Eye Study. Ophthalmology. 2007;114(1):121–6.
26.Nangia V, Matin A, Bhojwani K, Kulkarni M, Yadav M, Jonas JB. Optic disc size in a population-based study in central India: the Central India Eye and Medical Study (CIEMS). Acta Ophthalmol. 2008;86(1):103–4.